Skip to main content
The NCI Community Hub will be retiring in May 2024. For more information please visit the NCIHub Retirement Page:https://ncihub.cancer.gov/groups/ncihubshutdown/overview
close

HTT MDDT

Version 4
by (unknown)
Version 5
by (unknown)

Deletions or items before changed

Additions or items after changed

1 [MainPage Wiki Main Page]
2
3 -
== HTT and the Medical Device Development Tool Program Description==
+
== HTT and the Medical Device Development Tool Submission ==
4
5 We are crowdsourcing pathologists to collect data (images + pathologist annotations) that can be qualified by the ''' [MedicalDeviceDevelopmentTools FDA/CDRH medical device development tool (MDDT) program]'''. If successful, the MDDT qualified data, along with a statistical software package for data the analysis, will be available to any algorithm developer to be used to validate their algorithm performance in a submission to the FDA/CDRH.
6
7 -
Our pilot study has provided valuable feedback about issues needed to create a generalizable dataset fit for a regulatory purpose: study size, stratified sampling of the patient population, and required pathologist training and qualifications.
+
==== Original Proposal ====
8
9 -
We will next solicit feedback from the FDA via the MDDT program and from the broader digital pathology and AI community. Ultimately, we intend to share the dataset, statistical methods, and lessons learned.
+
Here is the original proposal submitted 15 November 2019.
10 +
* [[File(00_MDDTproposal_TILsAnnotatedDataset_Gallas-public.pdf)]]
11 +
12 +
We received feedback from FDA on 16 April 2020. We intend to summarize the feedback and how we have adapted our efforts.